Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02206841
What this trial is testing

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Who this might be right for
Fibrosis of Liver
Seoul National University Boramae Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT01617772
What this trial is testing

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Tehran University of Medical Sciences 440
Not applicableUnknownNCT05676177
What this trial is testing

CT Liver Fat Fraction Quantification

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatosis of Liver
Sheba Medical Center 150
Not applicableStudy completedNCT03836937
What this trial is testing

Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Sir Salimullah Medical College Mitford Hospital 70
Not applicableStudy completedNCT04117802
What this trial is testing

Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome

Who this might be right for
OverweightMicrobiotaEndotoxemia+3 more
Laval University 47
Not applicableLooking for participantsNCT05046483
What this trial is testing

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI

Who this might be right for
ST-segment Elevation Myocardial Infarction (STEMI)Diabetes MellitusInsulin Resistance+1 more
German Diabetes Center 300
Not applicableStudy completedNCT04671186
What this trial is testing

Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Northwell Health 47
Not applicableStudy completedNCT03369145
What this trial is testing

High-fat Overfeeding, Hepatokines and Appetite Regulation

Who this might be right for
Insulin ResistanceType2 Diabetes MellitusNon-Alcoholic Fatty Liver Disease+1 more
Loughborough University 12
Not applicableStudy completedNCT01110577
What this trial is testing

Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Merck Sharp & Dohme LLC 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07020377
What this trial is testing

Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).

Who this might be right for
Diabetes MellitusNon Alcholic Fatty Liver Disease
Amira Bisher,PhD 60
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Not applicableStudy completedNCT02884037
What this trial is testing

Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease
Mansoura University 50
Testing effectiveness (Phase 2)Study completedNCT01811472
What this trial is testing

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT04681573
What this trial is testing

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

Who this might be right for
NAFLD
University Hospital, Angers 1,045
Not applicableUnknownNCT05738707
What this trial is testing

Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06322628
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients

Who this might be right for
Nash
Visirna Therapeutics HK Limited 48
Not applicableStudy completedNCT06247137
What this trial is testing

Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation

Who this might be right for
Hypercholesterolemia
University of Bologna 90
Post-approval studies (Phase 4)Study completedNCT04639414
What this trial is testing

Combined Active Treatment in Type 2 Diabetes With NASH

Who this might be right for
Type 2 DiabetesNon-alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease (NAFLD)
German Diabetes Center 192
Not applicableUnknownNCT05790057
What this trial is testing

Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )

Who this might be right for
Liver Steatoses
Assiut University 60
Testing effectiveness (Phase 2)Study completedNCT00596934
What this trial is testing

Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Elif Oral 9
Next Page